Journal of Cancer Therapy

Vol.4 No.3A(2013), Paper ID 28932, 10 pages

DOI:10.4236/jct.2013.43A058

 

Cell Origin Subtypes Predict Outcomes in Localized-Stage Diffuse Large B-Cell Lymphoma Treated with Curative Radiotherapy

 

Yuko Watanabe, Hiroaki Suefuji, Etsuyo Ogo, Kensaku Sato, Tadashi Nakashima, Takashi Okamura, Koichi Ohshima, Naofumi Hayabuchi

 

Department of Radiology, Kurume University School of Medicine, Kurume, Japan
Department of Radiology, Kurume University School of Medicine, Kurume, Japan
Department of Radiology, Kurume University School of Medicine, Kurume, Japan
Biostastics Center, Kurume University School of Medicine, Kurume, Japan
Department of Otolaryngology, Head and Neck Surgery, Kurume University School of Medicine, Kurume, Japan
Department of Hematology and Oncology, Kurume University School of Medicine, Kurume, Japan
Department of Pathology, Kurume University School of Medicine, Kurume, Japan
Department of Radiology, Kurume University School of Medicine, Kurume, Japan

 

Copyright © 2013 Yuko Watanabe, Hiroaki Suefuji, Etsuyo Ogo, Kensaku Sato, Tadashi Nakashima, Takashi Okamura, Koichi Ohshima, Naofumi Hayabuchi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

 

How to Cite this Article


Y. Watanabe, H. Suefuji, E. Ogo, K. Sato, T. Nakashima, T. Okamura, K. Ohshima and N. Hayabuchi, "Cell Origin Subtypes Predict Outcomes in Localized-Stage Diffuse Large B-Cell Lymphoma Treated with Curative Radiotherapy," Journal of Cancer Therapy, Vol. 4 No. 3A, 2013, pp. 475-484. doi: 10.4236/jct.2013.43A058.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.